MP78: Prostate Cancer: Localized: Ablative Therapy

5/6/2019

9:30 AM - 11:30 AM

Location: MCP: W180

Abstract Presenter(s)

AA

Akbar Ashrafi, MD

USC Institute of Urology, Keck School of Medicine, University of Southern California
EB

Eduard Baco

Oslo University Hospital

Slides
RB

Romain Boissier
JF

Jonathan Fainberg

Slides
John Feller, MD

Loma Linda School of Medicine, UC Riverside School of Medicine

Slides
AK

Adam Kinnaird

Slides
LM

Lorenzo Marconi
SN

Shiva Nair
Aydin Pooli, MD

Urologic Oncology Fellow/Clinical Instructor
Department of Urology, David Geffen School of Medicine at UCLA
DR

Deepika Reddy
AS

Armando Stabile
Rafael Tourinho-Barbosa, MD

Institut Mutualiste Montsouris

Slides
JY

Jason Yang
MZ

Michael Zachareas
Steve Zhou

David Geffen School of Medicine at UCLA

Presentations:

9:30 AM - 11:30 AM
A comparison of cancer control outcomes at 5 years of Focal Therapy (using HIFU & cryotherapy) to Radical Prostatectomy for clinically significant non-metastatic prostate cancer: propensity score-matched analysis
Deepika Reddy
9:30 AM - 11:30 AM
A Contemporary Systematic Review of Partial Prostate Gland Ablation Outcomes: A Comparative Study of Thermal versus Non-Thermal Technologies
Jonathan Fainberg
9:30 AM - 11:30 AM
A phase II study to evaluate outpatient, transrectally-delivered, MRI-guided laser focal therapy of prostate cancer: 9 year interim results (NCT 02243033)
John F. Feller, MD
9:30 AM - 11:30 AM
ALL SALVAGE ROBOTIC RADICAL PROSTATECTOMIES ARE NOT CREATED EQUAL: COMPARISON OF FUNCTIONAL AND PERIOPERATIVE OUTCOMES ON POST FOCAL THERAPY VS. POST RADIOTHERAPY PATIENTS
Lorenzo Marconi
9:30 AM - 11:30 AM
CONCOMITANT FOCAL THERAPY AND ROBOTIC LYMPHADENECTOMY IN PROSTATE CANCER: INITIAL SERIES
Akbar N. Ashrafi, MD
9:30 AM - 11:30 AM
Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection
Jason Yang
9:30 AM - 11:30 AM
FOCAL CRYOABLATION IS ASSOCIATED WITH IMPROVED PATHOLOGICAL PROGRESSION-FREE COMPARED TO ACTIVE SURVEILLANCE IN GLEASON 6 PROSTATE CANCER
Akbar N. Ashrafi, MD
9:30 AM - 11:30 AM
Long term oncological outcomes of cryoablation and HIFU in whole gland and first line treatment for localized prostate cancer
Romain Boissier
9:30 AM - 11:30 AM
Median 5-year oncological outcomes of salvage high intensity focused ultrasound for prostate cancer recurrences after primary radiotherapy.
Shiva Nair
9:30 AM - 11:30 AM
Medium term oncological outcomes in a large cohort of men treated with either focal- or hemi-abaltion with HIFU for primary localized prostate cancer
Armando Stabile
9:30 AM - 11:30 AM
PREDICTING PATHOLOGIC TUMOR SIZE IN PROSTATE CANCER BASED ON MULTIPARAMETRIC PROSTATE MRI AND PREOPERATIVE FINDINGS.
Aydin Pooli, MD – UCLA Health
9:30 AM - 11:30 AM
Predicting Prostate Cancer Focal Therapy Eligibility with Machine Learning
Steve R. Zhou
9:30 AM - 11:30 AM
Predictive Factors of Failure Following Focal Therapy for Prostate Cancer
Rafael Tourinho-Barbosa, MD
9:30 AM - 11:30 AM
Predictors of biochemical recurrence after primary whole gland cryotherapy for prostate cancer
Adam Kinnaird
9:30 AM - 11:30 AM
Randomized control trial comparing focal prostate ablation and radical prostatectomy in patients with intermediate risk prostate cancer. Initial experiences.
Eduard Baco
9:30 AM - 11:30 AM
ROBOTIC ASSISTED RADICAL PROSTATECTOMY AFTER FOCAL THERAPY: ONCOLOGICAL AND FUNCTIONAL OUTCOMES
Lorenzo Marconi
9:30 AM - 11:30 AM
Safety Profile of Office Based MR/US Fusion Cryoablation: A Multi-Center Assessment
Michael Zachareas
9:30 AM - 11:30 AM
Salvage Possibilities After Focal Therapy Failure: Redo Focal Treatment versus Robotic Radical Prostatectomy Analysis
Rafael Tourinho-Barbosa, MD
9:30 AM - 11:30 AM
SITE OF DISEASE RECURRENCE FOLLOWING PROSTATE FOCAL THERAPY PREDICTS ONCOLOGICAL OUTCOME AFTER SALVAGE ROBOTIC ASSISTED RADICAL PROSTATECTOMY
Lorenzo Marconi
9:30 AM - 11:30 AM
Tumor control outcomes of salvage cryotherapy for radiorecurrent prostate cancer at median 12 years follow-up.
Shiva Nair